Prediction Markets Have No Place in Clinical Trials
2 min read
Kalshi just launched biotech prediction markets as a pilot program, letting the public bet on outcomes like FDA approvals and clinical trial results. We think that's a serious mistake.
Kalshi just launched biotech prediction markets as a pilot program, letting the public bet on outcomes like FDA approvals and clinical trial results. We think that's a serious mistake.
At this point, no one is unfamiliar with the convenience of modern AI tools. We use it everywhere, outsourcing tedious tasks so that we're unlocked to do bigger, better things. The ROI is obvious, but the risks are not.